Quarterly report pursuant to Section 13 or 15(d)

9. Supplemental Disclosure of Cash Flow Information (Details)

v3.5.0.2
9. Supplemental Disclosure of Cash Flow Information (Details) - USD ($)
 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Supplemental Cash Flow Elements [Abstract]    
Cash paid for interest $ 1,237,622 $ 222,898
Cash paid for income taxes 0 1,853,408
Non-cash investing and financing activities:    
Accrued liabilities settled through the issuance of common stock and warrants 2,131,829 0
Exercise of stock options as reduction of notes payable, related party 0 (2,500,000)
Assets acquired through capital leases 0 1,597,063
Acquisition of noncontrolling interest in Biohealth Medical Laboratory, Inc.:    
Deposits on acquisition 0 259,875
Goodwill 0 (138,871)
Noncontrolling interest $ 0 $ (121,004)